Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425471 · ClinicalTrials.gov registry record · NA
The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery
A NA study of In Utero Procedure Affecting Fetus or Newborn, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06425471: Recruiting NA study of In Utero Procedure Affecting Fetus or Newborn, sponsored by The University of Texas Health Science Center, Houston.
NCT06425471 is a NA study of In Utero Procedure Affecting Fetus or Newborn that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425471, a NA study of In Utero Procedure Affecting Fetus or Newborn, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery
Conditions Studied
Interventions
- DEVICE KARL STORZ fetoscope arm
Study Locations (1)
Texas
- The University of Texas health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-04 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06425471 shows while recruiting
NCT06425471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with In Utero Procedure Affecting Fetus or Newborn appearing as the primary indexed condition, and to 1 intervention - of which KARL STORZ fetoscope arm is the first listed.
NCT06425471 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06425471 about?
NCT06425471 is a clinical study titled "The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery". The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery
What is the current status of trial NCT06425471?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-04. Estimated completion is 2028-12-31.
What conditions does trial NCT06425471 study?
This clinical trial studies the following conditions: In Utero Procedure Affecting Fetus or Newborn.
What interventions are being tested in trial NCT06425471?
The interventions under investigation include: KARL STORZ fetoscope arm (DEVICE).
Who is sponsoring clinical trial NCT06425471?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425471 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for In Utero Procedure Affecting Fetus or Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06425471's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI